New Two-Pronged attack on inoperable liver cancer
NCT ID NCT07180459
Summary
This study is testing a two-part treatment for liver cancer that cannot be surgically removed. Doctors will use tiny, drug-filled beads to block the tumor's blood supply and deliver chemotherapy directly, while patients also take an oral medication called Donafenib. The goal is to see if this combination can better control the cancer, slow its progression, and help patients live longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Deng zhou People's Hospital
Nanyang, Henan, China
-
First People's Hospital of Shangqiu
Shangqiu, Henan, China
-
Huai He Hospital of Henan University
Kaifeng, Henan, China
-
Jiangxi Provincial People's Hospitail
Nanchang, Jiangxi, China
-
Luo He Central Hospital
Luohe, Henan, China
-
Luo Yang Central Hospital
Luoyang, Henan, China
-
People's Hospital of Kaiyang County
Guiyang, Guizhou, China
-
Second People's Hospital of Jiaozuo
Jiaozuo, China
-
The Second Affiliated Hospital of Hainan Medical Universsity
Haikou, Hainan, China
-
Zhou Kou Central Hospital
Zhoukou, Henan, China
Conditions
Explore the condition pages connected to this study.